Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Jasper Deuring

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|September 29, 2021
Ulcerative Colitis Narrative findings: Australian survey data comparing patient and physician disease management viewsSusan J Connor, Alexandra Sechi, Mauricio Andrade, et al.
Current Therapeutic Research, Clinical and Experimental|August 2, 2021
Tofacitinib Use in Adults with Chronic Inflammatory Disease During the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic: What Is Known So Far?Samantha Howland, J Jasper Deuring, Xiaofeng Zhou, et al.
Arthritis Research & Therapy|August 27, 2024
Machine learning prediction and explanatory models of serious infections in patients with rheumatoid arthritis treated with tofacitinibMerete Lund Hetland, Anja Strangfeld, Gianluca Bonfanti, et al.
The International Journal of Biochemistry & Cell Biology|January 8, 2013
The cell biology of the intestinal epithelium and its relation to inflammatory bowel diseaseJ Jasper Deuring, Colin de Haar, Ernst J Kuipers, et al.
Biochemical Society Transactions|July 27, 2011
Impeded protein folding and function in active inflammatory bowel diseaseJ Jasper Deuring, Maikel P Peppelenbosch, Ernst J Kuipers, et al.
The Biochemical Journal|August 26, 2011
Absence of ABCG2-mediated mucosal detoxification in patients with active inflammatory bowel disease is due to impeded protein foldingJ Jasper Deuring, Colin de Haar, Chantal L Koelewijn, et al.
Advances in Therapy|July 31, 2023
Modeling of Treatment Outcomes with Tofacitinib Maintenance Therapy in Patients with Ulcerative Colitis: A Post Hoc Analysis of Data from the OCTAVE Clinical ProgramMichael Chiorean, Marco Daperno, Charlie W Lees, et al.
Plos One|October 4, 2019
Pregnane X receptor activation constrains mucosal NF-κB activity in active inflammatory bowel diseaseJ Jasper Deuring, Meng Li, Wanlu Cao, et al.
Gut|August 22, 2013
Genomic ATG16L1 risk allele-restricted Paneth cell ER stress in quiescent Crohn's diseaseJ Jasper Deuring, Gwenny M Fuhler, Sergey R Konstantinov, et al.
Therapeutic Advances in Gastroenterology|February 14, 2022
Prediction of early clinical response in patients receiving tofacitinib in the OCTAVE Induction 1 and 2 studiesCharlie W Lees, J Jasper Deuring, Michael Chiorean, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|September 29, 2021
Ulcerative Colitis Narrative findings: Australian survey data comparing patient and physician disease management viewsSusan J Connor, Alexandra Sechi, Mauricio Andrade, et al.
Current Therapeutic Research, Clinical and Experimental|August 2, 2021
Tofacitinib Use in Adults with Chronic Inflammatory Disease During the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic: What Is Known So Far?Samantha Howland, J Jasper Deuring, Xiaofeng Zhou, et al.
Arthritis Research & Therapy|August 27, 2024
Machine learning prediction and explanatory models of serious infections in patients with rheumatoid arthritis treated with tofacitinibMerete Lund Hetland, Anja Strangfeld, Gianluca Bonfanti, et al.
The International Journal of Biochemistry & Cell Biology|January 8, 2013
The cell biology of the intestinal epithelium and its relation to inflammatory bowel diseaseJ Jasper Deuring, Colin de Haar, Ernst J Kuipers, et al.
Biochemical Society Transactions|July 27, 2011
Impeded protein folding and function in active inflammatory bowel diseaseJ Jasper Deuring, Maikel P Peppelenbosch, Ernst J Kuipers, et al.
The Biochemical Journal|August 26, 2011
Absence of ABCG2-mediated mucosal detoxification in patients with active inflammatory bowel disease is due to impeded protein foldingJ Jasper Deuring, Colin de Haar, Chantal L Koelewijn, et al.
Advances in Therapy|July 31, 2023
Modeling of Treatment Outcomes with Tofacitinib Maintenance Therapy in Patients with Ulcerative Colitis: A Post Hoc Analysis of Data from the OCTAVE Clinical ProgramMichael Chiorean, Marco Daperno, Charlie W Lees, et al.
Plos One|October 4, 2019
Pregnane X receptor activation constrains mucosal NF-κB activity in active inflammatory bowel diseaseJ Jasper Deuring, Meng Li, Wanlu Cao, et al.
Gut|August 22, 2013
Genomic ATG16L1 risk allele-restricted Paneth cell ER stress in quiescent Crohn's diseaseJ Jasper Deuring, Gwenny M Fuhler, Sergey R Konstantinov, et al.
Therapeutic Advances in Gastroenterology|February 14, 2022
Prediction of early clinical response in patients receiving tofacitinib in the OCTAVE Induction 1 and 2 studiesCharlie W Lees, J Jasper Deuring, Michael Chiorean, et al.
Pageof 2